TGFB2 and recessive dystrophic epidermolysis bullosa: In both cases cells were treated with test compounds and TGFβ2, a known inducer of C7 in human keratinocytes35 upregulated in RDEB lesions36 which was found to enhance the activity of reference compounds during the development of the AlphaLISA assay (Supplementary information Fig S1).